Quantum Private Wealth »

Crispr Therapeutics shares owned by Quantum Private Wealth

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Quantum Private Wealth from 13F filings

Historical chart of Quantum Private Wealth investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Quantum Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Quantum Private Wealth

Quarter filed Position value Share count Share price at filing
2025-12-31 $257k 4.9k 52.44

More positions owned by Quantum Private Wealth

Meta Platforms Cl A (META)
Amazon (AMZN)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Ab Active Etfs Disruptors Etf (FWD)
Netflix (NFLX)
Advanced Micro Devices (AMD)
Palantir Technologies Cl A (PLTR)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Taysha Gene Therapies Com Shs (TSHA)
Powell Industries (POWL)
Crowdstrike Hldgs Cl A (CRWD)

View all positions for Quantum Private Wealth

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital Research and Management Company - Division 3
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Geode Capital Management
Susquehanna International
Sr One Capital Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics